🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open-label, single-arm, multi-center, Phase IIa study to evaluate the effic...
Status
Unknown
Location
Research Site
Start Date
2016-12-22
Trial ID
NCT03190824
Treatments Being Tested
This phase I trial studies the side effects of OBP-301 when given together ...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-12-02
Trial ID
NCT04391049
Treatments Being Tested
The goal of this study is to learn about of the research study drug, telome...
Status
Recruiting
Location
Weill Cornell Medicine/NewYork-Presbyterian Hospital
Start Date
2024-04-25
Trial ID
NCT06340711
Treatments Being Tested
This is an open labeled, multiple centers, two countries (Taiwan and Korea)...
Status
Unknown
Location
Pusan National University Hospital
Start Date
2014-10
Trial ID
NCT02293850
Treatments Being Tested
This is a phase 1 study to evaluate safety and tolerability of Telomelysin ...
Status
Unknown
Location
Research site
Start Date
2017-07-07
Trial ID
NCT03213054
This is multicenter, open-label Phase I study to exploratively evaluate the...
Status
Completed
Location
National Cancer Center Hospital East
Start Date
2017-10-01
Trial ID
NCT03172819
Treatments Being Tested
The purpose of this study is to test the effects, of the research study dru...
Status
Terminated
Location
Weill Cornell Medicine
Start Date
2021-05-03
Trial ID
NCT04685499
Treatments Being Tested
This is a phase II study of OBP-301 with pembrolizumab in advanced gastric ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2019-05-09
Trial ID
NCT03921021
Treatments Being Tested